Epidemiology of invasive Escherichia coli disease in adults in England, 2013-2017

被引:0
|
作者
Blum, Maxim [1 ]
Geurtsen, Jeroen [2 ]
Herweijer, Eva [1 ]
Sarnecki, Michal [3 ]
Spiessens, Bart [4 ]
Diogo, Gil Reynolds [5 ]
Hermans, Peter [6 ]
Thelwall, Simon [7 ]
Bhattacharya, Alex [7 ]
Verstraeten, Thomas [1 ]
Poolman, Jan [2 ]
Hope, Russell [7 ]
机构
[1] P95 Epidemiol & Pharmacovigilance, Leuven, Belgium
[2] Janssen Vaccines & Prevent BV, Bacterial Vaccines Discovery & Early Dev, Leiden, Netherlands
[3] Janssen Vaccines, Bern, Switzerland
[4] Janssen Pharmaceut, Janssen Res & Dev, Infect Dis & Vaccines, Beerse, Belgium
[5] Janssen Cilag, High Wycombe, England
[6] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, South Africa
[7] UK Hlth Secur Agcy, London, England
关键词
ExPEC; Invasive <italic>E. coli</italic> Disease; IED; Incidence; Sepsis; Bacteraemia; Bloodstream infection; Fatality; Surveillance; Epidemiology; BLOOD-STREAM INFECTIONS; RISK-FACTORS; BACTEREMIA; BURDEN;
D O I
10.1017/S0950268824001584
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Extraintestinal pathogenic Escherichia coli (ExPEC) causes invasive E. coli disease (IED), including bacteraemia and (uro)sepsis, resulting in a high disease burden, especially among older adults. This study describes the epidemiology of IED in England (2013-2017) by combining laboratory surveillance and clinical data. A total of 191 612 IED cases were identified. IED incidence increased annually by 4.4-8.2% across all ages and 2.8-7.6% among adults >= 60 years of age. When laboratory-confirmed urosepsis cases without a positive blood culture were included, IED incidence in 2017 reached 149.4/100 000 person-years among all adults and 368.4/100 000 person-years among adults >= 60 years of age. Laboratory-confirmed IED cases were identified through E. coli-positive blood samples (55.3%), other sterile site samples (26.3%), and urine samples (16.6%), with similar proportions observed among adults >= 60 years of age. IED-associated case fatality rates ranged between 11.8-13.2% among all adults and 13.1-14.7% among adults >= 60 years of age. This study reflects the findings of other published studies and demonstrates IED constitutes a major and growing global health concern disproportionately affecting the older adult population. The high case fatality rates observed despite available antibiotic treatments emphasize the growing urgency for effective intervention strategies. The burden of urosepsis due to E. coli is likely underestimated and requires additional investigation.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Impact of Invasive Escherichia Coli Disease on Clinical Outcomes and Medical Resource Utilization Among Asian Patients in the United States
    Zhuo, Chao
    Zheng, Bo
    Wattanakamolkul, Kittima
    Nakayama, Yoshikazu
    Cloutier, Martin
    Gauthier-Loiselle, Marjolaine
    Feng, Jun
    Wu, David
    Neary, Maureen P.
    Geurtsen, Jeroen
    El Khoury, Antoine C.
    Gu, Yoshiaki
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (02) : 313 - 328
  • [42] Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative
    Baas, Paul
    Daumont, Melinda J.
    Lacoin, Laure
    Penrod, John R.
    Carroll, Robert
    Venkatesan, Sudhir
    Ubhi, Harveen
    Calleja, Alan
    Snee, Michael
    LUNG CANCER, 2021, 162 : 185 - 193
  • [43] Extended-spectrum β-lactamase-producing Escherichia coli isolation among older adults: Epidemiology and outcomes
    Farooq, Sameen
    Hayakawa, Kayoko
    Marchaim, Dror
    Pogue, Jason M.
    Kaye, Keith S.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2014, 42 (05) : 565 - 568
  • [44] Enhancement and external validation of algorithms using diagnosis codes to identify invasive Escherichia coli disease
    Hernandez-Pastor, Luis
    Geurtsen, Jeroen
    El Khoury, Antoine C.
    Fortin, Stephen P.
    Gauthier-Loiselle, Marjolaine
    Yu, Louise H.
    Cloutier, Martin
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (10) : 1303 - 1312
  • [45] Epidemiology of Escherichia coli bloodstream infection antimicrobial resistance trends across South West England during the first 2 years of the coronavirus disease 2019 pandemic response
    Stanley, Jack
    Sullivan, Brian
    Dowsey, Andrew W.
    Jones, Koren
    Beck, Charles R.
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (10) : 1291 - 1297
  • [46] Epidemiology and clinical burden of invasive pneumococcal disease in older adults in the city of Sao Paulo, Brazil
    Jarovsky, Daniel
    Cereda, Rosangela Ferraz
    Figueiredo, Licieri Marotta
    Berezin, Eitan Naaman
    da Silva, Thiago Junqueira Avelino
    Kairalla, Maisa Carla
    Fernandes, Milene
    Nascimento, Bruna Pascarelli Pedrico do
    Marcelino, Cicera Pimenta
    Batista, Paula de Mendonca
    de Paula, Marina Della Negra
    Moreira, Thais das Neves Fraga
    VACCINE, 2025, 54
  • [47] Serotype epidemiology of invasive pneumococcal disease in Swiss adults: A nationwide population-based study
    Meichtry, Jurka
    Born, Rita
    Kueffer, Marianne
    Zwahlen, Marcel
    Albrich, Werner C.
    Brugger, Silvio D.
    Muehlemann, Kathrin
    Hilty, Markus
    VACCINE, 2014, 32 (40) : 5185 - 5191
  • [48] Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution
    Munehisa Fukusumi
    Bin Chang
    Yoshinari Tanabe
    Kengo Oshima
    Takaya Maruyama
    Hiroshi Watanabe
    Koji Kuronuma
    Kei Kasahara
    Hiroaki Takeda
    Junichiro Nishi
    Jiro Fujita
    Tetsuya Kubota
    Tomimasa Sunagawa
    Tamano Matsui
    Kazunori Oishi
    BMC Infectious Diseases, 17
  • [49] Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution
    Fukusumi, Munehisa
    Chang, Bin
    Tanabe, Yoshinari
    Oshima, Kengo
    Maruyama, Takaya
    Watanabe, Hiroshi
    Kuronuma, Koji
    Kasahara, Kei
    Takeda, Hiroaki
    Nishi, Junichiro
    Fujita, Jiro
    Kubota, Tetsuya
    Sunagawa, Tomimasa
    Matsui, Tamano
    Oishi, Kazunori
    BMC INFECTIOUS DISEASES, 2017, 17
  • [50] Molecular Mechanisms and Epidemiology of Carbapenem-Resistant Escherichia coli Isolated from Chinese Patients During 2002-2017
    Tian, Xuebin
    Zheng, Xiangkuo
    Sun, Yao
    Fang, Renchi
    Zhang, Siqin
    Zhang, Xiucai
    Lin, Jie
    Cao, Jianming
    Zhou, Tieli
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 501 - 512